Artia Global Partners LP Ocular Therapeutix, Inc Transaction History

Artia Global Partners LP

  • $367 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$4.2 - $8.69 $943,677 - $1.95 Million
-224,685 Reduced 31.0%
500,000 $3.42 Billion
Q1 2024

May 15, 2024
BUY
$3.85 - $10.93 $1.1 Million - $3.11 Million
284,685 Added 64.7%
724,685 $6.59 Billion
Q4 2023

Feb 14, 2024
BUY
$2.08 - $4.52 $915,200 - $1.99 Million
440,000 New
440,000 $1.96 Billion

Others Institutions Holding OCUL

# of Institutions
172
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $705M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email